全文获取类型
收费全文 | 5339篇 |
免费 | 282篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 87篇 |
儿科学 | 347篇 |
妇产科学 | 82篇 |
基础医学 | 455篇 |
口腔科学 | 200篇 |
临床医学 | 480篇 |
内科学 | 1100篇 |
皮肤病学 | 159篇 |
神经病学 | 270篇 |
特种医学 | 127篇 |
外科学 | 860篇 |
综合类 | 162篇 |
一般理论 | 4篇 |
预防医学 | 209篇 |
眼科学 | 233篇 |
药学 | 453篇 |
中国医学 | 37篇 |
肿瘤学 | 372篇 |
出版年
2023年 | 58篇 |
2022年 | 130篇 |
2021年 | 245篇 |
2020年 | 125篇 |
2019年 | 180篇 |
2018年 | 254篇 |
2017年 | 175篇 |
2016年 | 205篇 |
2015年 | 215篇 |
2014年 | 292篇 |
2013年 | 346篇 |
2012年 | 407篇 |
2011年 | 466篇 |
2010年 | 238篇 |
2009年 | 192篇 |
2008年 | 244篇 |
2007年 | 241篇 |
2006年 | 235篇 |
2005年 | 194篇 |
2004年 | 176篇 |
2003年 | 162篇 |
2002年 | 138篇 |
2001年 | 65篇 |
2000年 | 55篇 |
1999年 | 40篇 |
1998年 | 37篇 |
1997年 | 29篇 |
1996年 | 18篇 |
1995年 | 20篇 |
1994年 | 22篇 |
1993年 | 13篇 |
1992年 | 26篇 |
1991年 | 40篇 |
1990年 | 33篇 |
1989年 | 38篇 |
1988年 | 46篇 |
1987年 | 30篇 |
1986年 | 24篇 |
1985年 | 29篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1981年 | 8篇 |
1979年 | 27篇 |
1978年 | 24篇 |
1977年 | 8篇 |
1976年 | 9篇 |
1974年 | 6篇 |
1973年 | 7篇 |
1969年 | 10篇 |
1968年 | 5篇 |
排序方式: 共有5637条查询结果,搜索用时 15 毫秒
1.
Tofacitinib is an immunosuppressive and disease-modifying therapy in rheumatoid arthritis. It may result in many infections flaring up. It is important to take precautions of all kinds (cardiovascular, malignancy, infections etc.) before starting tofacitinib. In this article, we have highlighted important steps where we need to take precautions before starting tofacitinib. 相似文献
2.
3.
Palat Balachandran M.S. M.Ch. Shaleen Agarwal M.S. M.Ch. Narendra Krishnani M.D. Chandra M. Pandey Ph.D. Ashok Kumar M.S. M.Ch. Sadiq S. Sikora M.S. Rajan Saxena M.S. Vinay K. Kapoor M.S. 《Journal of gastrointestinal surgery》2006,10(6):848-854
The aim of this study was to examine the predictors of long-term survival (>24 months) in patients with gall bladder cancer.
A retrospective review of 117 cases of gall bladder cancer resected between 1989 and 2000. The resections included 80 simple
cholecystectomies and 37 extended procedures. Patients with survival >24 months (n=44) were compared with those having survival
<24 months (n=73) for 17 prognostic factors. Overall median survival was 16 months with a 5-year survival of 27%. T status
(P=.000) and adjuvant chemoradiotherapy (P=.001) were independent predictors of long-term survival. Survival advantage was
seen in T3N+ve disease (P=.007) with extended procedures. Complete (R0) resection was attained in 30 patients with a 5-year
survival advantage of 30% as compared with incomplete (R1) resection (P=.0002). Adjuvant chemoradiotherapy improved survival
in simple cholecystectomy group (P=.0008) but no advantage was seen after extended procedures. Stage III (P=.001) and node-positive
disease (P=.0005) had significant benefit with adjuvant therapy. Poor differentiation and vascular invasion were associated
with poor long-term survival. R0 resection was associated with prolonged survival. Extended procedures improved survival in
patients with T3N+ve disease. Addition of chemoradiotherapy made significant improvement in long-term survival in stage III
and node-positive lesions and in patients undergoing simple cholecystectomy. R0 resection predicted long-term survival in
gall bladder cancer. T3 N+ve disease had better survival after extended procedures. Adjuvant chemoradiotherapy improved survival
in stage III and node-positive disease. Poor differentiation and vascular invasion were adverse predictors of survival. 相似文献
4.
5.
6.
Gunter Deppe M.D. Marc L. Kahn M.D. Vinay K. Malviya M.D. John M. Malone Jr. M.D. Carl W. Christensen M.D. Ph.D. 《Gynecologic oncology》1996,62(3):340-343
Experience with the P.A.S.-PORT, a peripherally implanted central venous access device, is evaluated in a retrospective review of 154 patients from July 1991 to June 1994. Blood could not be aspirated from six patients. Complications included temporary minor thrombophlebitis in seven patients (4.5%), symptomatic axillary or subclavian vein thrombosis in five patients (3.2%), clotted port in two patients (1.2%), port pocket cellulitis in two patients (1.2%), and fungal sepsis in two patients (1.2%). In six patients (3.8%) the P.A.S.-PORT had to be removed because of complications. The P.A.S.-PORT facilitated delivery of chemotherapy, parenteral nutrition, blood products, antibiotics, hydration, and blood sampling. It was demonstrated that the P.A.S.-PORT may be inserted and used with a low incidence of complications in gynecologic cancer patients. 相似文献
7.
8.
Susannah V Quisling Vinay A Shah Ho K Lee Bruno Policeni Wendy R K Smoker Coleman Martin Andrew G Lee 《Journal of neuro-ophthalmology》2006,26(1):47-48
A 44-year-old man with right-sided herpes zoster ophthalmicus (HZO) developed ipsilateral third and sixth cranial nerve palsies and first-division trigeminal (fifth cranial nerve) sensory loss. MRI revealed contrast enhancement of the cisternal and cavernous portions of the third cranial nerve and high signal on a FLAIR sequence within the ipsilateral medulla at the presumed location of the trigeminal nucleus and tract. To our knowledge, this is the first report of the combination of these imaging findings in HZO. 相似文献
9.
Immune responses induced by two dose strengths of an yeast-derived recombinant hepatitis B vaccine in adolescents. 总被引:2,自引:0,他引:2
10.
Intracranial Angioplasty and Stenting in the Awake Patient 总被引:1,自引:0,他引:1
Alex Abou-Chebl MD Derk W. Krieger MD Christopher T. Bajzer MD Jay S. Yadav MD FACC 《Journal of neuroimaging》2006,16(3):216-223
BACKGROUND AND PURPOSE: Endovascular treatment for intracranial atherosclerosis is evolving, but complications remain an issue. Most interventions are performed under general anesthesia, preventing intraprocedural clinical evaluations. We describe our approach to intracranial angioplasty and stenting, using local rather than general anesthesia, and intraprocedural neurological assessment. METHODS: We prospectively collected procedural and outcome information on all patients undergoing intracranial angioplasty and stenting. Patients underwent interventions under local anesthesia with mild intravenous sedation or analgesia only if needed. Intraoperative neurological evaluations were performed, and symptomatology was used to guide the interventional technique. RESULTS: Forty-eight arteries in 40 patients with a mean age of 65.2 years were treated. Thirty-two anterior and 16 posterior circulation segments were treated. Technical success was achieved in 100% of patients with reduction of the mean pretreatment stenosis from 85 +/- 8.6% to 7 +/- 10.1%. Stents were deployed in 40 segments; five patients were treated with drug-eluting stents. The cobalt-chromium coronary stents were the easiest to deliver. Thirty-seven patients were treated under local anesthesia and, of those, 61.4% experienced intraprocedural symptoms that led to some alteration of the interventional technique. Headache was the most common symptom, and, when persistent, it heralded the occurrence of subarachnoid hemorrhage. There were seven total neurological complications, but only five (10.5%) led to permanent morbidity (4 strokes) or mortality (1 death). CONCLUSIONS: Intracranial angioplasty and stenting can be successfully performed using coronary techniques and equipment including drug-eluting stents. Local anesthesia permits neurological evaluations and often leads to the adjustment of the interventional technique, potentially making the procedure safer. 相似文献